Simultaneous selection of nanobodies for accessible epitopes on immune cells in the tumor microenvironment

In the rapidly advancing field of synthetic biology, there is a critical need for technology to discover targeting moieties for therapeutic biologics. We developed INSPIRE-seq, an approach that utilizes a nanobody library and next-generation sequencing to identify nanobodies selected for complex environments. INSPIRE-seq enables the parallel enrichment of immune cell-binding nanobodies that penetrate the tumor microenvironment. Clone enrichment and specificity varies across immune cell subtypes in the tumor, lymph node, and spleen. INSPIRE-seq identified a dendritic cell binding clone that binds PHB2. Single-cell RNA sequencing revealed a connection with cDC1s, and immunofluorescence confirmed nanobody-PHB2 colocalization along cell membranes. Structural modeling and docking studies assisted binding predictions and will guide nanobody selection. In this work, we demonstrate that INSPIRE-seq offers an unbiased approach to examine complex microenvironments and assist in the development of nanobodies, which could serve as active drugs, modified to become drugs, or used as targeting moieties.

[1]  M. Araúzo-Bravo,et al.  The need to reassess single-cell RNA sequencing datasets: the importance of biological sample processing , 2021, F1000Research.

[2]  Oriol Vinyals,et al.  Highly accurate protein structure prediction with AlphaFold , 2021, Nature.

[3]  Jason W. Labonte,et al.  Ensuring scientific reproducibility in bio-macromolecular modeling via extensive, automated benchmarks , 2021, Nature Communications.

[4]  Benjamin K. Mueller,et al.  Modeling Immunity with Rosetta: Methods for Antibody and Antigen Design , 2021, Biochemistry.

[5]  Zemin Zhang,et al.  The history and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications , 2020, Cellular & Molecular Immunology.

[6]  Brian D. Weitzner,et al.  Macromolecular modeling and design in Rosetta: recent methods and frameworks , 2020, Nature Methods.

[7]  J. Wolchok,et al.  The future of cancer immunotherapy: microenvironment-targeting combinations , 2020, Cell Research.

[8]  Jeffrey J. Gray,et al.  Robustification of RosettaAntibody and Rosetta SnugDock , 2020, bioRxiv.

[9]  Jeffrey J. Gray,et al.  An expanded benchmark for antibody-antigen docking and affinity prediction reveals insights into antibody recognition determinants. , 2020, Structure.

[10]  E. Kenigsberg,et al.  A conserved dendritic-cell regulatory program limits antitumour immunity , 2020, Nature.

[11]  Nathan E. Reticker-Flynn,et al.  Melanoma-Secreted Lysosomes Trigger Monocyte-Derived Dendritic Cell Apoptosis and Limit Cancer Immunotherapy , 2020, Cancer Research.

[12]  A. Koong,et al.  Induced Tumor Heterogeneity Reveals Factors Informing Radiation and Immunotherapy Combinations , 2020, Clinical Cancer Research.

[13]  N. Slavov.  Unpicking the proteome in single cells , 2020, Science.

[14]  P. Hegde,et al.  Top 10 Challenges in Cancer Immunotherapy. , 2020, Immunity.

[15]  T. Lassmann,et al.  Systematic assessment of tissue dissociation and storage biases in single-cell and single-nucleus RNA-seq workflows , 2019, Genome Biology.

[16]  H. Kosako,et al.  Structural Basis of Mitochondrial Scaffolds by Prohibitin Complexes: Insight into a Role of the Coiled-Coil Region , 2019, iScience.

[17]  Yun-Gui Yang,et al.  Single-cell RNA-seq highlights intra-tumoral heterogeneity and malignant progression in pancreatic ductal adenocarcinoma , 2019, Cell Research.

[18]  G. Evan,et al.  Myc instructs and maintains pancreatic adenocarcinoma phenotype , 2019, bioRxiv.

[19]  Nobel work that galvanized an industry , 2018, Nature Biotechnology.

[20]  William Sheffler,et al.  Efficient Flexible Backbone Protein-Protein Docking for Challenging Targets , 2017, bioRxiv.

[21]  Ambrose J. Carr,et al.  Single-Cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment , 2018, Cell.

[22]  Brian D. Weitzner,et al.  RosettaAntibodyDesign (RAbD): A general framework for computational antibody design , 2017, bioRxiv.

[23]  O. Podhajcer,et al.  Single-Domain Antibodies and the Promise of Modular Targeting in Cancer Imaging and Treatment , 2018, Front. Immunol..

[24]  David Baker,et al.  Comprehensive computational design of ordered peptide macrocycles , 2017, Science.

[25]  G. Evan,et al.  Myc Cooperates with Ras by Programming Inflammation and Immune Suppression , 2017, Cell.

[26]  G. González-Sapienza,et al.  Single-Domain Antibodies As Versatile Affinity Reagents for Analytical and Diagnostic Applications , 2017, Front. Immunol..

[27]  Sean C. Bendall,et al.  Systemic Immunity Is Required for Effective Cancer Immunotherapy , 2017, Cell.

[28]  H. Stehr,et al.  Reprogramming the immunological microenvironment through radiation and targeting Axl , 2016, Nature Communications.

[29]  Brian D. Weitzner,et al.  Modeling and docking of antibody structures with Rosetta , 2017, Nature Protocols.

[30]  Jens Meiler,et al.  Improving Loop Modeling of the Antibody Complementarity-Determining Region 3 Using Knowledge-Based Restraints , 2016, PloS one.

[31]  Mikhail Pogorelyy,et al.  VDJtools: Unifying Post-analysis of T Cell Receptor Repertoires , 2015, PLoS Comput. Biol..

[32]  Sean C. Bendall,et al.  An interactive reference framework for modeling a dynamic immune system , 2015, Science.

[33]  T. Gajewski,et al.  Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity , 2015, Nature.

[34]  Edgar G. Engleman,et al.  Allogeneic IgG combined with dendritic cell stimuli induces anti-tumor T cell immunity , 2015, Nature.

[35]  Elizabeth L. Sander,et al.  Rarefaction and extrapolation with Hill numbers: a framework for sampling and estimation in species diversity studies , 2014 .

[36]  Serge Muyldermans,et al.  Nanobodies: natural single-domain antibodies. , 2013, Annual review of biochemistry.

[37]  R. Hodes,et al.  This information is current as in B Lymphocytes CD 86 Cooperate To Mediate CD 86 Signaling Prohibitins and the Cytoplasmic Domain of Hodes , 2012 .

[38]  R. Cardiff,et al.  Early vascular deficits are correlated with delayed mammary tumorigenesis in the MMTV-PyMT transgenic mouse following genetic ablation of the NG2 proteoglycan , 2012, Breast Cancer Research.

[39]  Beth Friedman,et al.  Fluorescent peptides highlight peripheral nerves during surgery in mice , 2011, Nature Biotechnology.

[40]  Kenneth W Dunn,et al.  A practical guide to evaluating colocalization in biological microscopy. , 2011, American journal of physiology. Cell physiology.

[41]  R. Tsien,et al.  Parallel in Vivo and in Vitro Selection Using Phage Display Identifies Protease-dependent Tumor-targeting Peptides* , 2010, The Journal of Biological Chemistry.

[42]  S. Muyldermans,et al.  Nanobodies as Tools for In Vivo Imaging of Specific Immune Cell Types , 2010, Journal of Nuclear Medicine.

[43]  Jeffrey J. Gray,et al.  SnugDock: Paratope Structural Optimization during Antibody-Antigen Docking Compensates for Errors in Antibody Homology Models , 2010, PLoS Comput. Biol..

[44]  D. Koller,et al.  The Immunological Genome Project: networks of gene expression in immune cells , 2008, Nature Immunology.

[45]  Vadim Zinchuk,et al.  Quantitative Colocalization Analysis of Multicolor Confocal Immunofluorescence Microscopy Images: Pushing Pixels to Explore Biological Phenomena , 2007, Acta histochemica et cytochemica.

[46]  F. Cordelières,et al.  A guided tour into subcellular colocalization analysis in light microscopy , 2006, Journal of microscopy.

[47]  Jeffrey J. Gray,et al.  High-resolution protein-protein docking. , 2006, Current opinion in structural biology.

[48]  E. Ruoslahti,et al.  Antitumor activity of a homing peptide that targets tumor lymphatics and tumor cells. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[49]  Simon C Watkins,et al.  Identification of a synovial fibroblast-specific protein transduction domain for delivery of apoptotic agents to hyperplastic synovium. , 2003, Molecular therapy : the journal of the American Society of Gene Therapy.

[50]  Erkki Ruoslahti,et al.  Organ targeting In vivo using phage display peptide libraries , 1996, Nature.

[51]  S. Muyldermans,et al.  Naturally occurring antibodies devoid of light chains , 1993, Nature.